Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Ischemic brain protection.

N G Bircher

    Annals of Emergency Medicine
    |August 1, 1985
    PubMed
    Summary
    This summary is machine-generated.

    Cardiopulmonary-cerebral resuscitation (CPCR) involves cerebral preservation during cardiac arrest and brain-oriented therapy after circulation restoration (ROSC). Promising pharmacologic agents are being studied for cerebral resuscitation, but none are clinically proven superior to intensive care.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Specialty neurointensive care--Is it just a name or a way of life?

    Critical care medicine·2001
    Same author

    Action sequence for layperson cardiopulmonary resuscitation.

    Annals of emergency medicine·2001
    Same author

    Intra-aortic administration of epinephrine above aortic occlusion does not alter outcome of experimental cardiopulmonary resuscitation.

    Resuscitation·1999
    Same author

    How low can you go? Blood pressure control after intracranial hemorrhage.

    Critical care medicine·1999
    Same author

    A comparison of techniques for placement of double-lumen endobronchial tubes.

    Journal of clinical anesthesia·1998
    Same author

    High-dose recombinant human erythropoietin stimulates reticulocyte production in patients with multiple organ dysfunction syndrome.

    The Journal of trauma·1998
    Same journal

    Variation in Emergency Department Experience With Pediatric Critical Illness.

    Annals of emergency medicine·2026
    Same journal

    Point-of-Care Ultrasound-Guided Hydrostatic Reduction of Ileocolic Intussusception in the Pediatric Emergency Department.

    Annals of emergency medicine·2026
    Same journal

    Managing Diabetic Ketoacidosis.

    Annals of emergency medicine·2026
    Same journal

    Needle Thoracostomy: Implications of Chest Wall Thickness for Anatomical Location and Needle Length.

    Annals of emergency medicine·2026
    Same journal

    Women Emergency Physicians and Gender Disparities from Entry to Advancement.

    Annals of emergency medicine·2026
    Same journal

    Policy Statements Approved March 2026.

    Annals of emergency medicine·2026
    See all related articles

    Area of Science:

    • Neurology
    • Cardiology
    • Critical Care Medicine

    Background:

    • Cerebral ischemia pathophysiology understanding has advanced, yet no single therapy surpasses brain-oriented intensive care.
    • Cardiopulmonary-cerebral resuscitation (CPCR) encompasses critical phases for brain recovery.

    Purpose of the Study:

    • To discuss basic concepts of CPCR, focusing on cerebral preservation and resuscitation phases.
    • To review pharmacologic agents under investigation for cerebral resuscitation efficacy.

    Main Methods:

    • Discussion of CPCR phases: cerebral preservation (during cardiac arrest) and cerebral resuscitation (post-restoration of spontaneous circulation [ROSC]).
    • Review of pharmacologic agents like barbiturates, calcium antagonists, and iron chelators for cerebral resuscitation.

    Related Experiment Videos

  • Emphasis on the 'therapeutic window' concept for evaluating drug efficacy.

    • Main Results:

    • Cerebral preservation strategies aim to maintain brain perfusion during cardiac arrest.
    • Cerebral resuscitation involves brain-directed therapies post-ROSC.
    • Several pharmacologic agents show promise, though clinical efficacy is not yet established.

    Conclusions:

    • No current cerebral resuscitation therapy has demonstrated clinical superiority over intensive care.
    • Pharmacologic agents for cerebral resuscitation are under investigation, with several showing potential.
    • Further research is needed to establish clinical efficacy and define optimal therapeutic strategies.